Pharma Mar, S.A.
- Jurisdiction
Spain - LEI
959800QWKZ45ZQC2AV58 - ISIN
ES0169501022 (PHM.MC )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
0
/ 7
Profile
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. Read full profile
Fundamentals
- Net revenue
€189.27M - Gross margin
95.0% - EBIT
€31.44M - EBIT margin
16.6% - Net income
€42.01M - Net margin
22.2%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
€0.80 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
33.2%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: March 4, 2023 (Q4 2022)